Materials Today Advances

NOV 5, 2026 · JOURNAL ARTICLE

Self-emulsifying drug delivery systems (SEDDS) for anticancer agents

Materials Today Advances

Background Cancer remains one of the leading causes of morbidity and mortality worldwide. Despite continuous advances in anticancer therapy, the clinical effectiveness of many anti

OCT 26, 2026 · JOURNAL ARTICLE

Hydroxybutyl chitosan oligosaccharide-coated hemocompatible nanoparticles for controlled drug release

Materials Today Advances

Objectives Hemocompatibility and controlled release properties are critical factors in designing drug delivery systems to enhance efficacy in cancer therapy. This study aimed to de

OCT 23, 2026 · JOURNAL ARTICLE

Artificial intelligence-assisted physiologically based pharmacokinetic modeling and large-scale machine learning analysis of tumor delivery of nanoparticles in mice

Materials Today Advances

Nanomedicine is a promising strategy for cancer therapy. However, the low delivery efficiency of nanoparticles (NPs) to tumors remains a challenge and hinders clinical translation.

OCT 1, 2026 · JOURNAL ARTICLE

HDACs-targeting photosensitizer-based local-therapy augmenting photoimmunotherapy in bladder cancer

Materials Today Advances

Immune checkpoint inhibitors (ICIs) represent a promising therapeutic strategy in bladder cancer (BCa), while limited response rates as monotherapy significantly restrict clinical

OCT 1, 2026 · JOURNAL ARTICLE

Artificial intelligence and machine learning-driven smart nanomedicine strategies to combat antimicrobial resistance

Materials Today Advances

Objective To explore the integration of artificial intelligence (AI), mainly machine learning (ML) and deep learning (DL), with nanotechnology, as a novel approach for countering a

SEP 26, 2026 · JOURNAL ARTICLE

PEG-Heparin hydrogels allow for the assessment of breast cancer tumouroid response to anti-cancer treatment for personalised medicine

Materials Today Advances

Objectives The validation of accurate three-dimensional (3D) models holds significant importance for anti-cancer drug development and screening processes, aiming to minimise the ti

SEP 11, 2026 · JOURNAL ARTICLE

Low-energy/low-dose unconventional cancer therapeutic approach using a radiosensitizing TMD-based hybrid nanosystem

Materials Today Advances

Two-dimensional (2D) nanomaterials including emerging post-graphene materials such as transition metal dichalcogenides (TMDs) have shown promising potential for different biomedica